polysaccharide (PSG-1)

Networked: 7 relevant articles (0 outcomes, 3 trials/studies)

1.	Sarcoma 180 04/27/2011 - "The aim of this study was to investigate the enhancement of Ganoderma atrum polysaccharide (PSG-1) on cyclophosphamide (CTX)-induced antitumor effect in sarcoma 180 (S-180)-bearing mice. "
2.	Hyperglycemia 09/23/2015 - "The aim of the present study was to examine the role of Ganoderma atrum polysaccharide (PSG-1) in reactive oxygen species (ROS) generation and mitochondrial function in hyperglycemia-induced angiopathy. "
3.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/01/2019 - "This study aimed at exploring the role of a Ganoderma atrum polysaccharide (PSG-1) in pancreatic damage in streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM) mice. "
4.	Neoplasms (Cancer) 04/17/2013 - "atrum polysaccharide (PSG-1) was investigated in vitro and in vivo using S180 tumor-bearing mice. " 06/01/2014 - "Ganoderma atrum polysaccharide (PSG-1) has been commonly suggested as a candidate for prevention and therapy of cancer. " 03/01/2011 - "Ganoderma atrum polysaccharide (PSG-1), the major active ingredient isolated from Ganoderma atrum, has been suggested as a candidate for cancer therapy. "
5.	Colitis 12/01/2020 - "atrum polysaccharide (PSG-1) on DSS-induced colitis and the underlying mechanism. "

1.	Reactive Oxygen Species (Oxygen Radicals)
2.	Streptozocin (Streptozotocin)
3.	Cyclophosphamide (Cytoxan)

1.	Therapeutics